XenaLives Thursday, 10/22/20 10:46:56 PM Re: None Post # of 300669 Compiled Due Diligence 09/29/19 & more ******** See this link: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151418975 ******* Possible meetings for data presentation ******* October 28-29, 2020 9.00-17.30 EDT | Virtual Event The inaugural Protein Misfolding Drug Discovery Digital Summit https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159044103 November 04, 2020 - November 07, 2020 https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158942181 Friday, November 6 Confirmed late breaking presentaton: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159068231 November 16-17, 2020 https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158943623 November 17, 2020[/b https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158968868 December 09-10, 2020 https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158931494 ********************************************************************** Updated Pipeline https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159068807 Biology concepts for Alzheimer’s disease (2/20 update) https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158531542 Covid and Anavex: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159068746 https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159069029 Updated Trials INSTRUCIONS TO VIEW UPDATES - https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159068404 PDD - https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159067462 RETT AVATAR - https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159067552 RETT - https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159067617 EARLY ALZHEIMER'S - https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159067667 New Parkinson’s news article re our positive PD Dementia trial results (from polarbear77) https://parkinsonsnewstoday.com/2020/10/19/anavex-2-73-safe-aids-cognitive-skills-parkinsons-dementia-patients-phase-2-trial/ Actigraph will give objective sleep data: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158938705 The slide that mentions Actigraphy: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158955971 More comments on Actigraphy https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157152758 Sleep - a few of many papers released within the last year: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158942413 PubChem reference for 2-73 https://pubchem.ncbi.nlm.nih.gov/compound/Anavex-2-73#section=Chemical-Disease-Co-Occurrences-in-Literature see also this post on pubchem info: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158822687 A new study finds new ways of detecting early, asymptomatic Alzheimer's disease (from falconer66): https://www.eurekalert.org/pub_releases/2020-10/wsu-rdm101920.php Effect of Peroxynitrite: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158822263 Autism and Mitochondrial Dysfunction: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158964035 https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158964348 TGA requirements have been discussed for years here. OLE's may be as valuable as a trial for the purpose of Provisional approval. https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158539684 ER–mitochondria signaling in Parkinson’s disease (from mapman's link to article post below) https://investorshub.advfn.com/boards/read_msg.aspx?message_id=142355746&txt2find=autophagy PDF of the article cited: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832754/pdf/41419_2017_Article_79.pdf From "Compiled: MOA and MEDICAL SCIENCE DISCUSSION 09/29/19" at the following link: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151418911 ALS and gut bacteria linked in “remarkable” new Harvard study (from georjejjl) https://newatlas.com/science/als-gut-bacteria-microbiome-harvard-study/ https://www.anavex.com/wp-content/uploads/2019/12/CTAD2019_ANAVEX2-73_P84_Microbiota_.pdf From MS Today and tradeherpete “Sigma-1 receptor agonists as potential protective therapies in multiple sclerosis”: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155546193 Aarsland has been busy: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158700775 Biostockclub holds forth :) https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158688526 Basic info on PDD from nidan: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158724733 Air pollution particles in young brains linked to Alzheimer's damage https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158774113 Faster drug approval coming world wide: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158796012 Ransomware attack possible reason for delay in PDD trial data: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158710802 https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158748463 https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158797284 The key lies in being able to accelerate the rate of failure. https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158828376 August 15, 2020 Media report on Rett Syndrome trial in Australia. https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158829938 COGNITION IN PARKINSON'S https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158855354 Anavex 2-73 made with the SCF, supercritical fluid, for increased bioavaliability. https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158825826 From JF comm. 10/08/20, w/ interesting PD comments and future---something about news in October: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158790564 Some of the scientific resources that MJFF utilizes, coordinates and makes available... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158897015 https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158897404